Infectious Diseases

September 29, 2022

VUMC lands grant to build top-line biosafety facility

Vanderbilt University Medical Center is set to construct a state-of-the-art BioSafety Level 3 (BSL3) facility for research involving the COVID-19 virus, anthrax and other dangerous microorganisms.

By Bill Snyder
Kaydi Naylor, 4, touches an eastern chain kingsnake at last week’s “MEGAMicrobe Express” community science fair at the Warner Elementary Arts Magnet School in East Nashville.
September 22, 2022

MEGAMicrobe event shows children that science can be fun

More than 100 children who attended the “MEGAMicrobe Express” community science fair on Sept. 17 at the Warner Elementary Arts Magnet School in East Nashville.

By Bill Snyder
Benoit Dawant, PhD, left, Erik Tkaczyk, MD, PhD, and colleagues have developed a new way to measure human monkeypox severity.
September 22, 2022

Vanderbilt study uses AI to speed mpox drug trials

A machine learning algorithm developed by researchers at Vanderbilt performs as well as humans at identifying skin lesions in clinical photographs of people with monkeypox.

By Paul Govern
September 7, 2022

VUMC study will evaluate alternative strategies for administering mpox vaccine

Rarely fatal, the mpox virus — spread by close, often skin-to-skin contact — causes a painful, blistering rash, fever, chills and other symptoms.

By Bill Snyder
August 16, 2022

Q&A: Reassurance for parents on mpox risk, spread and symptoms

A pediatric infectious diseases expert answers questions parents might have about the risk of mpox risk to children.

By Jessica Pasley
August 4, 2022

Study tracks limited use of influenza antiviral therapy

A Vanderbilt study found that more than half of children diagnosed with influenza and deemed high risk for flu-related complications were given the recommended antiviral treatment.

By Jessica Pasley
July 21, 2022

Study explores role RSV plays in later asthma development

A Vanderbilt clinical project will follow 1,950 Middle Tennessee children to determine how genes and the environment interact with RSV infection during the first year of life and contribute to asthma development
By Leah Mann
June 2, 2022

Bacterial battle in 3D

Using imaging mass spectrometry and microscopy, Vanderbilt researchers visualized how staph bacteria modifies lipids in its membrane to evade immune system-mediated killing.
By Bill Snyder
May 5, 2022

VUMC team discovers how bacterial pathogen survives without water

Vanderbilt researchers are studying a bacterial pathogen that can survive on hospital surfaces — without water — for months, an ability that has helped it become a leading cause of hospital-acquired infections.
By Leigh MacMillan
April 7, 2022

Study advances understanding of bacterial bioterrorism agent

Vanderbilt researchers have identified a critical regulatory factor in the bacterium that causes the disease anthrax and has been used as a biological weapon.
By Leigh MacMillan
March 17, 2022

Study compares kidney injury risk for COVID, flu patients

A Vanderbilt study found that renin-angiotensin-aldosterone system (RAASi) inhibitor drugs, which are commonly used to regulate high blood pressure, do not disproportionately increase the risk of acute kidney injury (AKI) in patients with COVID-19 compared to patients hospitalized with influenza.
By Emily Stembridge
February 28, 2022

Invasive strep can defy zinc toxicity

Vanderbilt researchers find that invasive Group B Streptococcus strains, a significant risk to pregnant patients and infants, can grow in presence of toxic zinc levels.
By Taylor Engdahl
February 24, 2022

Study to explore neurologic impact of flu treatment

A Vanderbilt study will explore the neurologic and psychiatric complications of flu and evaluate adverse effects of the antiviral treatment oseltamivir, also known by the brand name Tamiflu.
By Jessica Pasley
1 … 5 6 7 8 9 … 13